|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: AbbVie Advances its Pipeline
2
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
3
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
4
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
5